A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
about
A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study of the Combination of ...... all Lymphocytic Lymphoma (SLL)
@en
type
label
A Study of the Combination of ...... all Lymphocytic Lymphoma (SLL)
@en
prefLabel
A Study of the Combination of ...... all Lymphocytic Lymphoma (SLL)
@en
P17
P4844
P1050
P1476
A Randomized, Open-label, Phas ...... ll Lymphocytic Lymphoma (SLL).
@en
P17
P3098
NCT03462719
P580
2018-04-17T00:00:00Z
P582
2021-02-02T00:00:00Z